@entity1311 -eluting @entity384 of biliary XXXX after liver transplantation.

@entity1 @entity384 @entity850 @entity1311
AIM: To investigate the safety and effectiveness of endoscopic therapy with a @entity1311 -eluting balloon (PEB) for biliary @entity850 ( @entity850 ) after liver transplantation (LT). METHODS: This prospective pilot study enrolled 13 consecutive eligible @entity1 treated for symptomatic @entity850 after LT at the University Hospital of M  nster between January 2011 and March 2014. The @entity1 were treated by endoscopic therapy with a PEB and followed up every 8 wk by endoscopic retrograde cholangiopancreatography (ERCP). In cases of re-stenosis, further @entity384 with a PEB was performed. Follow-up was continued until 24 mo after the last intervention. RESULTS: Initial technical feasibility, defined as successful @entity384 with a PEB during the initial ERCP procedure, was achieved in 100% of cases. Long-term clinical success (LTCS), defined as no need for further endoscopic intervention for at least 24 mo, was achieved in 12 of the 13 @entity1 (92.3%). The mean number of endoscopic interventions required to achieve LTCS was only 1.7    1.1. Treatment failure, defined as the need for definitive alternative treatment, occurred in only one @entity1 , who developed recurrent stenosis with increasing bile duct dilatation that required stent placement. CONCLUSION: Endoscopic therapy with a PEB is very effective for the treatment of @entity850 after LT, and seems to significantly shorten the overall duration of endoscopic treatment by reducing the number of interventions needed to achieve LTCS.
